Dermapharm Holding SE (ETR:DMP)

Dermapharm Holding SE Revenue

Dermapharm Holding SE had revenue of 285.15M EUR in the quarter ending June 30, 2026, with 4.78% growth. This brings the company's total for the last twelve months to 1.18B, up 0.39% year-over-year. In the year 2025, Dermapharm Holding SE had annual revenue of 1.16B, down -1.34%. That makes Dermapharm Holding SE the 6,439th largest company in the world by revenue and 153rd in Germany.

• Revenue (ttm): 1.18B
• Revenue Growth: +0.39%
• P/S Ratio: 1.62
• Revenue / Employee: 326.70K
• Employees: 3,619
• Market Cap: 1.92B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Branded Pharmaceuticals 629.16M 52.6%
• Other Healthcare Products 363.84M 30.4%
• Parallel Import Business 203.44M 17.0%

By Geography

Chart

• Germany 696.40M 59.8%
• France 137.81M 11.8%
• Spain 119.10M 10.2%
• Others 116.57M 10.0%
• Austria/Switzerland 95.10M 8.2%

Fiscal year ended Dec 31, 2025 See the full Dermapharm Holding SE breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.16B	-15.79M	-1.34%
Dec 31, 2024	1.18B	45.42M	4.00%
Dec 31, 2023	1.14B	110.58M	10.79%
Dec 31, 2022	1.02B	81.86M	8.68%
Dec 31, 2021	942.91M	149.08M	18.78%
Dec 31, 2020	793.83M	92.95M	13.26%
Dec 31, 2019	700.88M	128.46M	22.44%
Dec 31, 2018	572.42M	105.31M	22.54%
Dec 31, 2017	467.12M	22.64M	5.09%
Dec 31, 2016	444.48M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error